Clinical significance of HMGA1 and HMGA2 expression in papillary thyroid carcinoma

汪运生,戴武,胡小磊,汪万英,宋志毅,项平,宋怀东,石建华
DOI: https://doi.org/10.3760/cma.j.issn.1000-6699.2015.01.005
2015-01-01
Abstract:Objective To study the relationship of high mobility group A (HMGA) 1 and HMGA2 expressions with the occurrence,development,and metastasis of papillary thyroid carcinoma.Methods Fresh and paraffin-embedded 35 cases of papillary thyroid carcinoma tissues (PTC) and corresponding paracancerous thyroid tissues (PT),and 10 cases of normal tissues (NT) from adjacent thyroid benign lesions were collected.The mRNA and protein expressions of HMGA1 and HMGA2 were detected by realtime PCR and immunohistochemistry respectively.Results The mRNA expressions of HMGA1 and HMGA2 showed nearly no expression in the NT group,no significant difference between PT group and NT group(P>0.05),and significantly higher expression in PTC group compared with NT group (173.5 folds and 5.9 folds,both P <0.01).The protein expressions of HMGA1 and HMGA2 gradually increased in NT group,PT group,and PTC group,with significant difference between these groups(both P<0.01).The protein expressions of HMGA1 and HMGA2 in PTC group with various clinical stages or with and without lymph node metastasis showed statistically significant difference (P <0.05 or P <0.01),but it did not show any significant difference regarding patients' age,gender,and tumor size(P>0.05).The mRNA and protein expressions of HMGA1 were significantly higher than those of HMGA2 in PTC group(P<0.05 or P<0.01).Conclusions The overexpressions of HMGA1 and HMGA2 were related to development and metastasis of papillary thyroid carcinoma.Compared with HMGA2,HMGA1 was a better molecular marker in identifying benign and malignant thyroid tumors.
What problem does this paper attempt to address?